# OnCo record hetero (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/hetero/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "hetero" ;
  schema:name "Hetero Drugs"@en ;
  schema:description "A privately held Hyderabad generics group, the world's largest maker of HIV antiretrovirals, which launched Indian biosimilars of rituximab in 2015 and bevacizumab in 2016."@en ;
  schema:url <https://onco.cc/companies/hetero/>, <https://hetero.com> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Hetero_Drugs> ;
  owl:sameAs <http://www.wikidata.org/entity/Q17054856> ;
  schema:citation <https://web.archive.org/web/20220505192107/https://www.heteroworld.com/> ;
  schema:addressCountry "IN" ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:technologies <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd20/>, <https://onco.cc/targets/vegf/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/bevacizumab/> ;
  onco:terms <https://onco.cc/terms/biosimilar/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-global-access/> .